Webinars by Medical Specialty - Neurology

Neuromyelitis optica Spectrum Disorders: AQP4 and MOG

Author: Levy, Michael, MD, PhD
Date: Tuesday, November 13, 2018
Category: For Credit, Webinar
Description: Dr. Levy discusses the shift in nosology of autoimmune central nervous system diseases from localization to antigen specificity, explain the differences between AQP4 and Myelin... Read more 

Diagnostic Biomarkers in Alzheimer’s Disease

Author: Acosta, Lealani Mae, MD, MPH
Date: Sunday, August 12, 2018
Category: For Credit, Webinar
Description: Dr. Acosta describes the clinical diagnosis of Alzheimer’s disease (AD), discusses pathological changes and outlines the currently available AD biomarkers.

At the... Read more 

Genetic Testing of Cognitive Disorders

Author: Swerdlow, Russel H., MD
Date: Sunday, May 06, 2018
Category: For Credit, Webinar
Description: Dr Swerdlow describes when genetic testing of cognitive disorders may be indicated, explains when genetic testing of cognitive disorders may be diagnostically helpful as well... Read more 

Hearing Loss in a Genetic World

Author: Krasner, Meagan, MS, LCGC
Date: Wednesday, February 28, 2018
Category: For Credit, Webinar
Description: Ms. Krasner discusses the genetic heterogeneity of hearing loss, when to consider genetic testing for hearing loss and what type of testing, and also describes... Read more 

Approach and Molecular Diagnosis of Epileptic Encephalopathies

Author: Guerrero, Rubén Bonilla, MD, FACMG, FACB, CGMBS
Date: Monday, January 01, 2018
Category: Webinar
Description: This educational webinar is presented in Spanish.

At the end of this webinar, participants will be able to:
• Review the... Read more 

Duchenne Muscular Dystrophy: Exon Skipping and PMO technology

Author: O'Rourke, Erin, MS, CGC
Date: Wednesday, December 06, 2017
Category: For Credit, Webinar
Description: Ms. O’Rourke reviews molecular basis of Duchenne Muscular Dystrophy (DMD), describes exon skipping and Phosphorodiamidate Morpholino Oligomer (PMO) technology, and discusses DMD diagnostic testing: challenges... Read more 

Alzheimer’s Disease: The Role of Amyloid Beta 42/40 in Risk Assessment

Author: Clarke, Nigel J., PhD
Date: Wednesday, November 15, 2017
Category: For Credit, Webinar
Description: Dr. Clarke discusses new innovations in AD biomarker-assay development and utilization, driven by the use of tandem mass spectrometry in lieu of previously used ELISA... Read more 

Autoimmune Neurology in the Diagnostic Laboratory

Author: Naides, Stanley J., MD., FACP, FACR
Date: Tuesday, October 24, 2017
Category: Webinar
Description: Dr. Naides discusses the role of autoantibodies in autoimmune neurological diseases, describes the methods used to detect autoantibodies in autoimmune neurological diseases and explains the... Read more 

The Emerging Field of Autoimmune Neurology

Author: Vernino, Steven, MD, PhD
Date: Wednesday, September 06, 2017
Category: For Credit, Webinar
Description: Dr. Vernino describes the concept and spectrum of autoimmune neurological disorders, explains the role and interpretation of neurological autoantibodies as diagnostic tests and reviews the... Read more 

Breakthroughs in Alzheimer’s Disease Assessment: Quantitation of CSF Beta Amyloid 40 & 42

Author: Clarke, Nigel J., PhD
Date: Wednesday, June 14, 2017
Category: For Credit, Webinar
Description: Dr Clarke discusses the advantages in assessing Alzheimer’s disease by measurement of amyloid beta 42/40 ratio, describes an improved LC-MS/MS approach for quantitating amyloid beta... Read more